NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)

Technical Analysis Report for NASDAQ stock ALNY Alnylam Pharmaceuticals. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Opened at 329.41 and Closed at: 325.07, which is -2.41% of previous session's close. It moved within a range of 323.16 and 334.42
The session was a Bearish session with an average volume of 1302300, which is -20.54% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 2 days back on short term averages

Support for tomorrow is 318.49 and resistance for tomorrow is 329.75
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 320.68, 316.29 resistance for tomorrow's hourly charts is 331.94, 338.81

10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 331.96 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 329.26 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 359.45 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 404.31 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Alnylam Pharmaceuticals is 390.86 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Alnylam Pharmaceuticals is at 329.26 and 200 DMA is at 390.86, while 50 DMA and 100 DMA are at 359.45 and 404.31 respectively

Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 329.26 and 20 EMA is at 334.05

Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 359.45 and 50 EMA is at 357.4

Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 404.31 and 100 EMA is at 378.4

Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 390.86 and 200 EMA is at 373.72

Tiziana Life has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Tiziana Life, about 9.65% more returns!

Sutro Biopharma has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Sutro Biopharma, about 46.17% more returns!

Pulse Biosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Pulse Biosciences, about 41.86% more returns!

Pavmed Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Pavmed Inc, about 12.83% more returns!

Intellia Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 25.82% more returns!

Nektar Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 83.51% more returns!

Minerva Neurosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 47.56% more returns!

Alnylam Pharmaceuticals has performed better than Medicinova Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Lemaitre Vascular has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 30.33% more returns!

Alnylam Pharmaceuticals has performed better than Amphastar Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Compugen has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Compugen, about 31.23% more returns!

Alnylam Pharmaceuticals has performed better than Corcept Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Dbv Technologies has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Dbv Technologies, about 10.93% more returns!

Dariohealth Corp has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Dariohealth Corp, about 5.86% more returns!

Electrocore Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Electrocore Inc, about 35.61% more returns!

Hologic Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Hologic Inc, about 8.7% more returns!

Henry Schein has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 18.85% more returns!

Immucell Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Immucell Corporation, about 19.59% more returns!

Ionis Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 4.49% more returns!

Alnylam Pharmaceuticals Technical analysis of indicators

Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Alnylam Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Alnylam Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 332.25 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.

Alnylam Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ALNY Experts View which covers a lot of information including buying and selling signals

ALNY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet